Cite
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase.
MLA
Sun, Yaoliang, et al. “Discovery of a Potent and Selective Proteolysis Targeting Chimera (PROTAC) Degrader of NSD3 Histone Methyltransferase.” European Journal of Medicinal Chemistry, vol. 239, Sept. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2022.114528.
APA
Sun, Y., Zhang, Y., Chen, X., Yu, A., Du, W., Huang, Y., Wu, F., Yu, L., Li, J., Wen, C., Yang, H., Shi, Q., Geng, M., Huang, X., & Xu, S. (2022). Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase. European Journal of Medicinal Chemistry, 239, N.PAG. https://doi.org/10.1016/j.ejmech.2022.114528
Chicago
Sun, Yaoliang, Ying Zhang, Xiaoai Chen, Aisong Yu, Wenhao Du, Yuting Huang, Feifei Wu, et al. 2022. “Discovery of a Potent and Selective Proteolysis Targeting Chimera (PROTAC) Degrader of NSD3 Histone Methyltransferase.” European Journal of Medicinal Chemistry 239 (September): N.PAG. doi:10.1016/j.ejmech.2022.114528.